Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) shows aggressive clinical behavior, but the treatment options are limited due to lack of a specific target. TNBC shares many clinical and pathological similarities with BRCA-deficient breast cancer, for which poly(ADP-ribose) polymerase (PARP) inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Na Young, Kim, Dan Hyo, Cho, Bong Jun, Choi, Eun Jung, Lee, Jong-Soo, Wu, Hong-Gyun, Chie, Eui Kyu, Kim, In Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355140/
https://www.ncbi.nlm.nih.gov/pubmed/25884663
http://dx.doi.org/10.1186/s12885-015-1090-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355140/
https://www.ncbi.nlm.nih.gov/pubmed/25884663
http://dx.doi.org/10.1186/s12885-015-1090-7

Ejemplares similares